Atlas Trials

Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies

Clinical trial NCT05570188 · WITHDRAWN

Trial details

NCT number
NCT05570188
Sponsor
Kunming Hope of Health Hospital
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
B-cell LymphomaB-cell Leukemia
Start date
2022-10-01
Primary completion
2024-10-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.